Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
(D-ala2)-methionine-enkephalinamide (DAME) was injected into the third cerebral ventricle of unrestrained cats. At ambient temperature (Ta) = 22 degrees C, 3.1-50 micrograms caused dose-related hyperthermias. As dosage was increased, the hyperthermias diminished and in some cats
hypothermia
developed. Hyperthermia was not due to pyrogenic contamination or prostaglandin synthesis since it was not altered by pretreatment with a large IV dose of indomethacin. However, pretreatment with naloxone did cause a dose-related reduction in the hyperthermia. A low dose of DAME (12.5 micrograms) also caused hyperthermia at Ta = 4 and 32 degrees C, indicative of an increase in the level about which body temperature was regulated. On the other hand, a dose of 200 micrograms, which caused hyperthermia Ta = 22 and 32 degrees C, usually caused
hypothermia
at Ta = 4 degrees C, perhaps due to impairment of thermoregulatory control mechanisms. The response to DAME in the cold was reduced by naloxone pretreatment or reversed by subsequent injection of naloxone. Differences in hyperthermic patterns over a range of TaS and the lack of hypothermogenic action of morphine indicate that DAME alters thermoregulation in the cat by acting on morphine-insensitive, but naloxone-sensitive receptors. Central injection of
beta-endorphin
(5-50 micrograms) caused a dose-related hyperthermia. (Des-tyr1)-leucine-enkephalin (10-250 micrograms) was weakly hyperthermogenic, and kyotorphin (500 micrograms) did not consistently alter body temperature.
...
PMID:Thermoregulatory effects of (D-ala2)-methionine-enkephalinamide in the cat. Evidence for multiple naloxone-sensitive opioid receptors. 625 Jun 78
In view of the close structural similarity between the pro-opiocortin fragment,
gamma-MSH
, and ACTH/MSH-type peptides, the behavioural profile of
gamma-MSH
was explored. Attention was first focused on behavioural procedures in which ACTH/MSH-related neuropeptides have been found effective. It was found that
gamma-MSH
and ACTH-like neuropeptides had opposite effects on avoidance behaviour. In this respect the activity of
gamma-MSH
resembles that of opiate antagonists rather than that of
beta-endorphin
. Accordingly, ACTH(1-24) induced excessive grooming which is blocked by opiate antagonists and is attenuated by
gamma-MSH
. In addition,
gamma-MSH
injected into the periaqueductal grey matter of the brainstem of opiate-naive rats elicited symptoms reminiscent of those seen after opiate withdrawal.
Gamma-MSH
attenuated several effects of intracerebroventricularly administered
beta-endorphin
(e.g. antinociception,
hypothermia
,
alpha-MSH
release) and decreased the acquisition of heroin self-administration. Although
gamma-MSH
at rather high doses displaced naloxone from its specific binding sites in brain homogenates, it did not interfere with
beta-endorphin
-induced effects on in vitro muscle preparations (guinea-pig ileum; rat rectum). Interestingly,
gamma-MSH
induced relaxation of the rat rectum in vitro. It is postulated that
gamma-MSH
may attenuate
beta-endorphin
-induced effects by acting via
gamma-MSH
receptor sites (functional antagonism), although a pharmacological antagonism cannot be excluded as yet.
...
PMID:Gamma-melanotropin and brain function. 626 81
Adrenocorticotropin (ACTH) and alpha-melanotropin (
alpha-MSH
) occur in brain tissue known to be important to temperature control. These peptides cause
hypothermia
if they are injected centrally in sufficient doses, but they do not act on the central set point of temperature control. Instead they appear to inhibit central pathways for heat conservation and production. In addition to their hypothermic capability, these peptides are antipyretic when given centrally in doses that have no effect on normal body temperature. ACTH has previously been associated with fever reduction in both clinical and experimental studies, and it may be that endogenous central ACTH is important for limitation of maximal fever. The hypothermic and antipyretic effects of ACTH do not depend on stimulation of the adrenal cortex because they are also observed in adrenalectomized rabbits. Nor is the antipyretic effect limited to the rabbit inasmuch as a comparable effect has been demonstrated in the squirrel monkey. The two peptides may be involved in central mediation of normal thermoregulation and fever, perhaps limiting the febrile response and other rises in body temperature by acting as neurotransmitters or neuromodulators in central thermoregulatory pathways.
...
PMID:ACTH and alpha-melanotropin in central temperature control. 627 99
The effect of intracerebroventricular injection of
beta-endorphin
(beta-END) on body temperature of mice was studied at ambient temperatures (Ta) of 10 degrees, 20 degrees and 31 degrees C. Doses between 0.1 and 10.0 microgram/mouse were studied. The lower (less than 1 microgram) doses of beta-END produced a hyperthermia at all Ta's studied. The higher doses of beta-END produced hyper- or
hypothermia
depending on the Ta. The subcutaneous injection of naloxone (1 mg/kg) antagonized the high dose hypothermic effects, but not the hyperthermic effect of beta-END. These data suggest that there may be different receptors and/or sites of action for high and low doses of beta-END.
...
PMID:Effects of beta-endorphin on body temperature in mice at different ambient temperatures. 627 45
Hypothalamic and ruminal cooling raised serum thyrotropin (TSH),
adrenocorticotropin
(ACTH), norepinephrine (NE), and glucose in conscious goats in 20 degree C ambient temperature. Cooling of the preoptic anterior hypothalamus (POAH) for 2 h initially evoked shivering and vasoconstriction, leading to 1.5 degree C rise in rectal temperature (Tr). Pituitary-thyroid activation by POAH cooling was shown by peak rises in TSH of 60% at 40 min, in triiodothyronine (T3) of 54% at 80 min, and in thyroxine (T4) of 40% at 140 min. At 60 min, ACTH and NE peaked at 57 and 65%, respectively. TSH, ACTH, and NE declined during the 2nd h of POAH cooling as Tr plateaued; when POAH cooling was stopped, these hormones fell below basal level as vasodilation and panting restored Tr to normal. In contrast to the core hyperthermia evoked by POAH cooling, ruminal intubation with O degree C water (1 liter/10 kg) led to general
hypothermia
, Tpoah and Tr falling 1.6 degree C at 40 min. Pituitary-thyroid responses were less but ACTH and NE more, compared with POAH cooling. TSH peaked at 37% at 20 min, T3 at 55% at 60 min, and T4 at 18% at 200 min. ACTH peaked at 250% at 30 min and NE at 120% at 20 min. Thermosensitive neurons in the POAH seem to mediate more sensitive and complete control over TSH than over ACTH, or NE release, whereas extrahypothalamic core thermosensitivity (e.g., brain stem, spinal cord, abdomen) may influence ACTH and NE more than TSH release.
...
PMID:Hypothalamic control of endocrine thermogenesis. 627 12
Intracerebroventricular administration of 20, 40 and 60 nmol of dynorphin (1-13) produced analgesia, as assessed by flinch/jump response to footshock, and
hypothermia
in the rat. Rats developed tolerance to both the analgesic and thermic effects of the 20 nmol dose of dynorphin. Dynorphin and
beta-endorphin
showed cross-tolerance with respect to their analgesic but not their thermic effects. Dynorphin and morphine also produced cross-tolerant analgesic effects. Naloxone (10 mg/kg, IP) completely blocked the barrel rolling produced by 20 nmol dynorphin but did not alter its analgesic or thermic effects.
...
PMID:Dynorphin (1-13): analgesia, hypothermia, cross-tolerance with morphine and beta-endorphin. 628 45
The mechanism underlying the hyperthermia induced by intrahypothalamic administration of either morphine or
beta-endorphin
has been investigated in conscious rats. Direct administration of morphine (1--8 micrograms in 1 microliter) or
beta-endorphin
(1--3 micrograms in 1 microliter) into the anterior hypothalamus caused hyperthermia in rats at the ambient temperature (8, 22 and 30 degrees C) studied. The hyperthermia in response to opiods was brought about by both increased metabolism and cutaneous vasoconstriction. This hyperthermia, unlike the
hypothermia
induced by intraventricular administration of opiods was not blocked by naloxone nor did tolerance develop to the response. However, the
hypothermia
induced by intrahypothalamic administration of opioids was greatly reduced by pretreatment with intrahypothalamic administration of either yohimbine (a blocking agent of alpha-adrenergic receptors) or DL-propranolol (a blocking agent of beta-adrenergic receptors) in the rat. These observations suggest that an adrenergic link occurs in the hypothalamic pathways which mediate morphine- and
beta-endorphin
-induced hyperthermia in the rat.
...
PMID:An adrenergic link in the hypothalamic pathways which mediates morphine- and beta-endorphin-induced hyperthermia in the rat. 628 55
Opioid peptides may act as neuromodulators in the central nervous system to conserve energy stores and water in mammals. To examine this hypothesis in man, the effect of opiate receptor blockade with naloxone on the hunger, thirst, and hypothermic response to 2-deoxy-D-glucose-induced glucoprivic stress was assessed. Opiate receptor blockade decreased stress-induced food intake but did not reduce marked increases in hunger produced by glucoprivation. Naloxone infusions did not change the hypercortisolemic, polydipsic, hypothermic, and thermogenic response to 2-deoxy-D-glucose. While these results do not suggest a major role for a
beta-endorphin
modulation of stress-induced hunger,
hypothermia
and water conservation, the reduction of food intake could be due to augmented satiety, perhaps associated with retardation of gastric emptying during opiate receptor blockade.
...
PMID:Opiate receptor blockade in man reduces 2-deoxy-D-glucose-induced food intake but not hunger, thirst, and hypothermia. 629 33
The effects of CRF, ACTH 1-24,
alpha-MSH
, and an ACTH 4-49 analog, at doses of 0, 0.1, 1, and 10 mg/kg, were tested on temperature, ptosis, and sedation in mice pretreated 18 hr previously with reserpine. IP injection of CRF at doses of 1 and 10 mg/kg significantly potentiated the reserpine-induced
hypothermia
while ACTH 1-24 at the same two doses had the opposite effect of significantly reversing the
hypothermia
as compared to diluent. The highest dose of
alpha-MSH
exerted a similar action to that of ACTH 1-24, but none of the doses of the ACTH 4-9 analog changed body temperature.
beta-endorphin
also failed to cause a reliable effect even though naloxone blocked the action of CRF on body temperature. The results suggest that CRF, like other hypothalamic peptides, can exert extra-pituitary actions after peripheral administration.
...
PMID:Opposite effects of CRF and ACTH on reserpine-induced hypothermia. 629 33
The effects of the three peptides neurotensin,
beta-endorphin
, and bombesin on ethanol-induced behaviors were studied in mice. Intracisternal administration of these peptides to mice prolonged the duration of sleep induced by ethanol (5.2 g/kg). Neurotensin and
beta-endorphin
also enhanced ethanol-induced
hypothermia
. None of the peptides, when administered alone, produced sleep. However, all three compounds impaired the aerial righting reflex and induced sleep when followed by an IP dose of ethanol (3.5 g/kg), which alone did not induce sleep. These results, taken together with previous findings, suggest that neuropeptides may be involved in the complex mechanisms of action of ethanol on the CNS.
...
PMID:The effects of neurotensin, beta-endorphin, and bombesin on ethanol-induced behaviors in mice. 630 2
<< Previous
1
2
3
4
5
6
7
8
Next >>